Cystic Fibrosis Microbiome-determined Antibiotic CFMATTERS Barry Plant UCC Therapy Trial in Exacerbations: Results Stratified. Coordinator Cystic Fibrosis Microbiome-determined Antibiotic CFMATTERS Catherine Stanton Teagasc, Food research Centre Therapy Trial in Exacerbations: Results Stratified. MERLIN Stephen Elliman Orbsen Therapeutics Ltd A Phase 1b/II study of MEK1/2 inhibitor PD-0325901 MerCuRIC Bryan Hennessy RCSI with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients. A Phase 1b/II study of MEK1/2 inhibitor PD-0325901 MerCuRIC Ciaran Clissman Pintail with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients. Social innovation to improve physical activity and EuroFFIT Pintail Ciaran Clissman sedentary behaviour through elite European football clubs: European Fans in Training. PanCare Studies in Fertility and Ototoxicity to Improve PanCareLife Julianne Byrne Boyne Research Centre Quality of Life after Cancer during Childhood, Adolescence and Young Adulthood. PanCare Studies in Fertility and Ototoxicity to Improve PanCareLife Ciaran Clissman Pintail Quality of Life after Cancer during Childhood, Adolescence and Young Adulthood. Global initiative on gene-environment interaction on InterConnect Donal O’Gorman DCU diabetes/obesity risk. Global initiative on gene-environment interaction on InterConnect Ciaran Duffy Enterprise Ireland diabetes/obesity risk. Hepatic and Cardiac Toxicity Systems modelling HeCaToS Richard Fernandes Luxcel Biosciences Limited Randomised controlled trial to evaluate electronic eSmart Eileen Furlong & UCD system management using the Advanced Symptom Patricia Fox System (ASyMS) Remote Technology for patients with cancers. THE MILESTONE PROJECT: Managing the Link and MILESTONE Fiona McNicholas UCD Strengthening Transition from Child to Adult Mental
Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified. CFMATTERS Barry Plant Coordinator UCC Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified. CFMATTERS Catherine Stanton Teagasc, Food research Centre MERLIN Stephen Elliman Orbsen Therapeutics Ltd A Phase 1b/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients. MerCuRIC Bryan Hennessy RCSI A Phase 1b/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients. MerCuRIC Ciaran Clissman Pintail Social innovation to improve physical activity and sedentary behaviour through elite European football clubs: European Fans in Training. EuroFFIT Ciaran Clissman Pintail PanCare Studies in Fertility and Ototoxicity to Improve Quality of Life after Cancer during Childhood, Adolescence and Young Adulthood. PanCareLife Julianne Byrne Boyne Research Centre PanCare Studies in Fertility and Ototoxicity to Improve Quality of Life after Cancer during Childhood, Adolescence and Young Adulthood. PanCareLife Ciaran Clissman Pintail Global initiative on gene-environment interaction on diabetes/obesity risk. InterConnect Donal O’Gorman DCU Global initiative on gene-environment interaction on diabetes/obesity risk. InterConnect Ciaran Duffy Enterprise Ireland Hepatic and Cardiac Toxicity Systems modelling HeCaToS Richard Fernandes Luxcel Biosciences Limited Randomised controlled trial to evaluate electronic system management using the Advanced Symptom System (ASyMS) Remote Technology for patients with cancers. eSmart Eileen Furlong & Patricia Fox UCD THE MILESTONE PROJECT: Managing the Link and Strengthening Transition from Child to Adult Mental MILESTONE Fiona McNicholas UCD